Sodium Chloride Ophthalmic Solution Recalled for Sterility Assurance Issues
Sterling Pharmaceutical Services is recalling Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an ophthalmic product, which poses a significant risk of infection.
Plain-English summary
Sterling Pharmaceutical Services LLC is recalling Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, sterile, 0.5 FL OZ (15 mL) bottles. The product is distributed by Reliable-1 Laboratories LLC in Valley Stream, NY, and carries NDC 69618-077-55.
The recall was initiated due to a lack of assurance of sterility. The affected units include 11,083 bottles distributed nationwide in the United States. Specific lots affected are Lot #3192 with an expiration date of 01/31/2027, and Lots #3293 and #3336 with an expiration date of 06/30/2027.
Consumers should stop using the product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC SOLUTION, 5% (SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC SOLUTION, 5%)
- Brand
- SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC SOLUTION, 5%
- Manufacturer
- Sterling Pharmaceutical Services LLC
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 11,083
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #3192
- Exp Date 01/312027
- 3293
- 3336 Exp Date 06/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Sterling Pharmaceutical Services LLC
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereWalgreens Lubricant Eye Drops Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereWalgreens Lubricant Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-09-30
- SevereSterling Recalls Major LubriFresh P.M. Ointment for Sterility Concerns
FDA (Drugs) · 2026-09-30
Same hazard · sterility
See all →- SeverePreferred Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereEagle Pharma Recalls Phenylephrine Infusion Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- SevereEagle Pharma Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- SevereHeparin Sodium Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-28
Similar recalls
- SevereAltaire Recalls Sodium Chloride Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- HighSodium Chloride Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- SevereWalgreens Sodium Chloride Ophthalmic Ointment Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereSterling Pharmaceutical Recalls Lubricating Tears Due to Sterility Concerns
FDA (Drugs) · 2026-09-30
- HighAltaire Recalls Altachlore Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27